Lps escherichia coli o111 b4 l2630
LPS (Escherichia coli O111:B4; L2630) is a laboratory product supplied by Merck Group. It is a lipopolysaccharide (LPS) derived from the Escherichia coli O111:B4 strain. LPS is a major component of the outer membrane of Gram-negative bacteria and is commonly used in research applications.
Lab products found in correlation
4 protocols using lps escherichia coli o111 b4 l2630
Endotoxin Shock Induction Protocol
LPS, Nigericin, and DOTAP Modulation of Inflammatory Responses
Analytical Grade Chemicals Protocol
Labrum Explant Culture for Inflammatory Modeling
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!